Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginia Braem

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Medwave|November 20, 2014
[Patient safety, – a current and ongoing problem]Carlos Alberto Díaz, Virginia Braem, Amalia Giuliani, et al.
The Lancet. Infectious Diseases|May 8, 2025
Real-world effectiveness of RSVpreF vaccination during pregnancy against RSV-associated lower respiratory tract disease leading to hospitalisation in infants during the 2024 RSV season in Argentina (BERNI study): a multicentre, retrospective, test-negative, case-control studyGonzalo Pérez Marc, Carla Vizzotti, Deshayne B Fell, et al.
Vaccine|April 3, 2025
Immunogenicity and safety of monovalent and bivalent SARS-CoV-2 variant adapted RBD-based protein booster vaccines in adults previously immunized with different vaccine platforms: A phase II/III, randomized clinical trialGonzalo Perez Marc, Lorena M Coria, Ana Ceballos, et al.
The New England Journal of Medicine|January 6, 2021
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older AdultsRomina Libster, Gonzalo Pérez Marc, Diego Wappner, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Medwave|November 20, 2014
[Patient safety, – a current and ongoing problem]Carlos Alberto Díaz, Virginia Braem, Amalia Giuliani, et al.
The Lancet. Infectious Diseases|May 8, 2025
Real-world effectiveness of RSVpreF vaccination during pregnancy against RSV-associated lower respiratory tract disease leading to hospitalisation in infants during the 2024 RSV season in Argentina (BERNI study): a multicentre, retrospective, test-negative, case-control studyGonzalo Pérez Marc, Carla Vizzotti, Deshayne B Fell, et al.
Vaccine|April 3, 2025
Immunogenicity and safety of monovalent and bivalent SARS-CoV-2 variant adapted RBD-based protein booster vaccines in adults previously immunized with different vaccine platforms: A phase II/III, randomized clinical trialGonzalo Perez Marc, Lorena M Coria, Ana Ceballos, et al.
The New England Journal of Medicine|January 6, 2021
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older AdultsRomina Libster, Gonzalo Pérez Marc, Diego Wappner, et al.
Pageof 1